Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose

Endocrinology
A B DamholtH Kofod

Abstract

Glucagon-like peptide-1(7-36)amide (GLP-1) is a potent insulinotropic peptide released from the small intestine. To investigate the regulation of GLP-1 secretion, we established a GLP-1 release assay based on primary canine intestinal L-cells. The ileal mucosa was digested with collagenase/EDTA to a single cell suspension and enriched for L-cells by counterstream centrifugal elutriation. We performed release assays on the cultured cells after 36 h, and GLP-1 in the supernatant was determined by enzyme-linked immunoabsorbent assay (ELISA). Glucose-dependent insulinotropic peptide (GIP) dose dependently stimulated the release of GLP-1 and resulted in a 2-fold increase at 100 nM GIP. This effect was fully inhibited by 10 nM somatostatin. However, neither basal or GIP stimulated GLP-1 secretion were affected by ambient glucose concentrations from 5-25 mM. The receptor-independent secretagogues beta phorbol myristate acetate and forskolin dose dependently increased the secretion of GLP-1; effects inhibited by staurosporine and H8 respectively. Costimulation with GIP and phorbol ester, but not forskolin, resulted in an additive response. Furthermore, the effect of GIP could be inhibited by H8 but not by staurosporine. These results i...Continue Reading

References

Dec 1, 1992·Molecular and Cellular Endocrinology·M A WahlH P Ammon
Apr 1, 1991·European Journal of Clinical Investigation·R GökeB Göke
Oct 1, 1965·The Journal of Clinical Endocrinology and Metabolism·N McIntyreD S Turner
Dec 1, 1967·The Journal of Clinical Investigation·M J Perley, D M Kipnis
Oct 1, 1995·The Journal of Endocrinology·C Herrmann-RinkeB Göke
Oct 1, 1994·The American Journal of Physiology·T J KiefferR A Pederson
Oct 1, 1964·The Journal of Clinical Endocrinology and Metabolism·H ELRICKY ARAI

❮ Previous
Next ❯

Citations

Jan 26, 2010·Nature Reviews. Endocrinology·Francesco RubinoTimothy E McGraw
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·K MiyawakiY Seino
Oct 24, 2003·BMC Physiology·Ian L P Beales, John Calam
Jul 26, 2002·Regulatory Peptides·Juris J MeierBaptist Gallwitz
Jul 12, 2005·Expert Opinion on Investigational Drugs·Octaviano A RogesAthena Philis-Tsimikas
Nov 13, 2008·The Journal of Physiology·Gwen TolhurstFiona M Gribble
Aug 23, 2011·Progress in Neurobiology·Fadi H Mourad, Nayef E Saadé
Mar 23, 2005·Regulatory Peptides·Carolyn F Deacon
Aug 6, 2011·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·E PaschettaG Musso
Dec 2, 2008·Cell Metabolism·Frank ReimannFiona M Gribble
Feb 11, 2014·Animal Science Journal = Nihon Chikusan Gakkaihō·Mohammad M MonirSang Gun Roh
Dec 3, 2016·Molecular and Cellular Endocrinology·Maria HaugeThue W Schwartz
Feb 18, 2016·Therapeutic Advances in Endocrinology and Metabolism·Ramona PaisFrank Reimann
Aug 20, 2016·Inflammatory Bowel Diseases·Claus H Bang-BerthelsenKlaus S Frederiksen
Jan 14, 2004·Canadian Journal of Physiology and Pharmacology·Patricia L Brubaker, Younes Anini
Dec 22, 1999·Endocrine Reviews·T J Kieffer, J F Habener
May 29, 2000·American Journal of Physiology. Endocrinology and Metabolism·L HansenJ J Holst
Jan 6, 2010·Expert Reviews in Molecular Medicine·Helen E ParkerFiona M Gribble
Jun 29, 2017·American Journal of Physiology. Endocrinology and Metabolism·Chee W ChiaJosephine M Egan
Jun 11, 1999·The American Journal of Physiology·C C TsengM M Wolfe
Mar 6, 2010·International Dairy Journal·Frank Reimann
Aug 28, 2002·Diabetes·Frank Reimann, Fiona M Gribble

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.